NOSEnews

September 2020


In This Issue:


President's Report

Robert C. Kern, MD, FARS

Dear Colleagues:

On behalf of the American Rhinologic Society (ARS), I am pleased to invite all those interested in Rhinologic disease to our 66th annual meeting, virtual this year in the face of the Covid-19 pandemic.  These are trying times for everyone and the move to a virtual meeting was the only practical answer. Very special notes of gratitude are due to many people. First, is Joe Han and the entire program committee, who have worked very closely to organize the many facets of this meeting, plowing new ground and stretching the limits of virtual technology to bring you the best experience possible. Wendi, Tammy and Susan have also worked tirelessly behind the scenes, dealing with all sorts of new challenges. The ARS is committed to providing first class educational material to our members, and despite the current pandemic, I think you will be very pleased. I would also like to thank our sponsors who have continued to generously support the society.  It has been my great pleasure to serve as your President over the past year, and despite the pandemic, it has been a wonderful and exciting experience, full of friendship and camaraderie as well as problem solving on the fly.  The current tough times will pass, and I am certain our organization will continue to do even more great things in the future. I thank you for the chance to serve as a steward of such a wonderful organization.

Back to the top


Executive Vice President’s Report

Michael G. Stewart MD, MPH, FARS

These times are testing everyone and everything, and medical societies are no exception. However, the American Rhinologic Society (ARS) will make it through this, because we have adequate reserves to withstand the loss of revenue, and because we have outstanding members and an important mission. All ARS members should be very proud of the remarkable efforts of so many of our members and leaders to persevere during these difficult times. I hesitate to name names, because I might exclude someone accidentally, so I apologize in advance for any omissions.

I first want to recognize ARS President Robert Kern, MD, FARS who has showed great flexibility and wisdom in dealing with many unexpected challenges, and he has kept the Society on track. President-Elect Joseph Han, MD, FARS is responsible for our meetings, which have been the most disrupted part of our work, but working with the Program Committee, he has done an amazing job of steering a new course and creating an exciting Virtual Meeting format. The leaders of our Summer Sinus Symposium (SSS) – Drs. Greg Davis, Marc Dubin and Doug Reh – have had to move the meeting (twice!) and change the format, but they have persevered and we look forward to a successful Virtual SSS in November.

Todd Kingdom, MD, FARS and David Poetker, MD, FARS worked seamlessly with the Fellowship Directors and the San Francisco Match to move the interviews and match dates for next year’s Fellows. Erin O’Brien, MD, FARS and the membership committee have been addressing important membership issues, and Troy Woodard, MD, FARS and the newly created Diversity and Inclusion Committee have been working to address diversity and inclusion issues in the society, which has proven to be very timely. Jivianne Lee, MD, FARS leads the Women in Rhinology Section, and they have been continuing their important work as well.

Kevin Welch, MD, FARS is our Treasurer and he has been keeping a close eye on our finances. Brent Senior, MD, FARS has stayed in contact with all of our industry partners who are anxious to continue to work with us, and he has also helped to organize some well-received Webinars on Covid-19 and Rhinology. And last but certainly not least, Spencer Payne, MD, FARS and the IT committee have been working extremely hard on our meeting program logistics, maintaining our website, and facilitating communications with our members.

And finally, of course our administrative staff are critical to the success of the ARS and that is certainly true now; Wendi Perez, Susan Arias and Tammy Lorimer have been loyal and supportive, and are putting in extra effort to ensure that our programs continue for the benefit of our membership.

Please join me in thanking our volunteer leaders and our staff for all their efforts for the American Rhinologic Society.

Back to the top


President-Elect’s Report

Joseph K. Han MD, FARS

Welcome to the 66th Annual American Rhinologic Society (ARS) Meeting. This will be the first virtual ARS Annual meeting. As your President-Elect, I appreciate the opportunity to serve as program chair for 2020. In the year 2020, it has been a turbulent and unexpected year that has been full of twist and turns.

The Program Committee has reviewed 217 abstracts for COSM ARS meeting and 221 abstracts for the annual meeting. We owe the program committee a huge debt of gratitude for their tireless work in ensuring the finest possible meeting content.

After careful consideration and discussions, ARS have developed the first ever virtual ARS annual meeting. The Covid-19 virus has impacted rhinologists significantly because of the high viral load in the nose, sinuses, and skull base. It has created an environment in which we have to consider how to take extra precautions to protect patients, medical staffs, and ourselves from the virus. It has also even impacted the timely ability to care for patient who require treatment. Therefore, creating a virtual program made sense this year and we have created a program that would minimize the impact for you and your care for your patients. The Annual meeting will be a 2 day program, starting Thursday evening and continuing on Saturday. It will be a combination of live panels to allow for immediate interactions and recorded scientific presentations with live time for questions and discussions. The virtual format will allow for possibilities that have not been available in the past like instantaneous online chatting, networking, and discussion.

The program will begin Thursday evening with the David Kennedy Lectureship featuring Peter Hwang as the speaker and the title is "Moving Forward: Rhinology in the post-COVID era". The lecture is very timely. We will also be highlighting the top 10 scientific abstracts from both the ARS COSM abstracts and ARS Annual Meeting abstracts which were selected in a blinded fashion by the Program Committee. We will also showcase a multidisciplinary panel on the management for chronic rhinosinusitis with nasal polyps.

Saturday afternoon or morning based on your residence, we will break up into three rooms with multiple sessions in each room. The panels will cover diverse concepts ranging from understanding the use of biologics, impact of COVID-19 on the rhinology practice, international perspective on the management of chronic rhinosinusitis, and evidence based approach to the management of allergic rhinitis. One of the panels is sponsored by Women in Rhinology and will talk about “Work-life balance during COVID-19 era”. There is no doubt that there is a large amount of material and definitely something for everyone in this year’s Fall meeting.

One of the benefits to this year virtual meeting is that you do not have to run from one room to another to hear the interesting talks. You can simply click from one room to another room. The top ten oral presentations will have 10 minutes to present their information, oral presentations will have 7 minutes, and new to this year is the format of the poster sessions. Each poster will be allowed 3 minutes to present their scientific presentations. If there are conflicting talks you want to hear, don’t worry because we will record the presentations and panels so that they will be available for viewing at a later time. However these recordings will be available only for a limited time so make sure you view all the wonderful abstracts.

The rhinology scientific content does not end on Saturday. If you are a paid ARS registrant, you will be able to have access to the AAO-HNS rhinology week, September 24 to 27. During this week, there will be several interesting rhinology panels. A couple of interesting panels during the rhinology week is a joint ARS/AAO-HNS panel discussing the tips and trick to endoscopic pituitary surgery and a joint ARS/AAOA panel discussing the work up and management of nasal polyps.

It has been an honor and a pleasure to serve as President-Elect and Program Chair and I look forward to seeing you in person in Los Angeles!

Back to the top



Rhinocast: An Exciting New Virtual Platform for American Rhinologic Society Education!

Brent A. Senior, MD, FACS, FARS

Vice President of Development and Strategic Initiatives

With the sudden disruption of our in-person educational offerings caused by the Covid-19 pandemic, the American Rhinologic Society (ARS) rapidly mobilized this spring to create a new platform to fill this educational gap: Rhinocast. This “lemonade from lemons” education tool was designed to provide an interactive, Zoom panel-type format, addressing timely topics for rhinologists by leaders in the field.

As with all educational products from the ARS, you can be sure that the information seen and heard in Rhinocasts is relevant, accurate, and unbiased, all while providing much needed CME hours for our physician community. AND ALL FOR FREE!

Six sessions have been produced so far, addressing the concerns of the community to learn how Covid-19 was affecting practices, and how to manage the “reboot” as we all started to open again. Numerous practical topics were addressed including “What is an aerosol-generating procedure?”, “How do we train residents and fellows in the middle of a pandemic?”, “What is appropriate personal protective equipment for nasal endoscopy or nasal debridement?”, “How do we manage the patient on immunotherapy during the pandemic?” Reinforcing the need for this platform, the reception to these lectures has been outstanding, with over 400 listeners for each of the events, including individuals from around the world!

But don’t worry if you have missed them! These dynamic discussions were all recorded and remain available to members under the “COVID Resources” tab on the ARS website: American-Rhinologic.org.

Stay tuned for additional Rhinocasts coming this fall. Planned topics on offer will include “Where Do Polyps Come From? New Ideas on Pathophysiology and How This Impacts Your Practice”; “Biologics: Is Sinus Surgery Dead?”; “How Do We Manage Failed Sinus Surgery?”
Announcements and details for these will be coming soon.

The ARS seeks to be the leader in reliable, timely, unbiased rhinologic education for clinicians and patients. Rhinocast is a dynamic, exciting platform to achieve this, and one which we hope you will be enjoying and learning from for many years to come.

Certainly, we can’t produce these products and distribute them for free without the support of our corporate rhinologic partners. I would like to thank these companies for partnering with us for our first series of Rhinocasts including Medtronic, Optinose, and MicrogenX. We look forward to welcoming others in the fall.

Back to the top


Summer Sinus Symposium Update

Greg Davis, MD, FARS

Marc Dubin, MD, FARS

Doug Reh, MD, FARS

Announcement: The American Rhinologic Society (ARS) Summer Sinus Symposium (SSS) 2020 is going virtual.

Due to the persistence of COVID-19 throughout the US, the SSS originally scheduled to take place in Miami, will now be virtual. We feel this is the most responsible way to facilitate a world class meeting during these challenging times.

SSS 2020 will take place online November 14th and 15th, 2020 with a reduced registration fee. If you have already registered for the meeting, we will automatically move your registration to this virtual meeting and will refund you the balance. If you have not yet registered for the virtual SSS meeting, we encourage you to do so: https://cvent.me/GVnAQ1

The program will feature live panels addressing your most pressing questions in Rhinology. There will also be moderated prosections from previously recorded surgeries with live Q&A. Additionally, during the intermissions there will be many breakout symposiums sponsored by our corporate sponsors for you to learn about new devices, techniques, medications, and instruments.

The meeting will be recorded to allow participants to either watch live or watch later when more convenient for their schedules.

Please hold your calendar for SSS 2021 in Austin TX July 23-25. Also, we will finally make it to Miami for SSS July 29-31, 2022.

Thank you for your understanding and ongoing support for the ARS.

Back to the top


Diversity and Inclusion Committee Update

Troy D. Woodard MD, FACS, FARS

Diversity and Inclusion Committee Chair / Diversity Officer

In January 2020, the American Rhinologic Society (ARS) Board and Committee Chairs convened for our first strategic planning retreat in several years. At that meeting, there was unanimous agreement that the ARS needed to update its Diversity and Inclusion Mission Statement and appoint a leader and a committee to address Diversity and Inclusion for the ARS. I agreed to become our inaugural Diversity Officer as well as Chair of our new Diversity and Inclusion Committee. Current committee membership includes Jean Anderson Eloy MD, FARS, Jivianne Lee MD, FARS, Jose Mattos MD, Erin O’Brien MD, FARS, Kenneth Rodriguez MD, Zach Soler MD, FARS, and Danielle Warner MD. The committee will study and implement plans to increase the diversity and inclusion of the ARS and its activities. They also welcome input from ARS Members.

Since its inception, the Diversity and Inclusion Committee has created a new Diversity and Inclusion Mission Statement for the Society:

“The American Rhinologic Society (ARS) is committed to diversity and inclusion within the membership of our society.

In order to fulfill our mission of promoting excellence in patient care, research, and education in rhinology and skull base disorders, we are committed to respecting, promoting, and valuing the contributions of members regardless of their age, ethnicity, gender, race, disability status, economic circumstances, religion or sexual orientation.

We will actively work to improve the inclusion and participation of diverse members at all levels including in committees and leadership and in educational offerings and research support.

The ARS will advance culturally competent patient care and research and the role of diversity in the ARS membership to further these efforts.”

Back to the top


Women in Rhinology Section Update

Jivianne T. Lee, MD, FARS

The American Rhinologic Society will be hosting the Annual Meeting virtually this year on September 10th and 12th, and we are excited to announce a panel sponsored by the Women in Rhinology (WiR) entitled “Work-life integration during the COVID-19 Era.” This panel will include the perspectives of both male and female rhinologists with a focus on how they are navigating their personal and professional lives during this trying time. We hope you can join us for what is sure to be an interesting panel.

Another important WiR event that will take place during the virtual meeting is the election of our next Governing Council. We are currently asking for nominations through the following link: https://www.american-rhinologic.org/wir-nomination . You may nominate yourself or someone else, and males are encouraged to nominate their female colleagues. A list of the open positions and a description of each are also included in the above link. The deadline for nominations is Tuesday September 8th.

The Women in Rhinology CORE grant is still on track for 2021, so stay tuned for further details about this exciting opportunity.
As always, to keep up-to-date on WiR events and initiatives, please follow us on Twitter (@women_rhinology) and IG (women_in_rhinology).
Stay safe out there!

Jivianne T. Lee, MD, FARS - Chair: [email protected]
Elina Toskala, MD, FARS – Chair Elect: [email protected]
Patricia Loftus, MD, FARS – Information Officer: [email protected]
Stephanie Joe, MD, FARS – Financial Officer: [email protected]
Stephanie Shintani Smith, MD – Research Chair: [email protected]
Danielle Warner, MD – Member at Large: [email protected]
Lauren Luk, MD – Member at Large: [email protected]

Back to the top


Allergy and Immunology in Rhinology Section Contributing to Virtual Meetings

Amber Luong, MD, PhD, FARS

These crazy COVID days are not keeping us from meeting and contributing to the latest updates in rhinology. At the upcoming virtual American Rhinologic Society (ARS) Fall meeting, the Allergy and Immunology Section (AIR) will be participating in the panel on Saturday September 12th from 1:10 – 2 pm EST moderated by Dr. Amber Luong entitled “Understanding the Role, Questions, and Concerns of Biologic in the Management of Nasal Polyps.” The panelists include Drs. Christine Franzese, Jean Kim, Kent Lam, Lauren Roland, and Rodney Schlosser. We now formally have 1 year experience with the first FDA approved biologic for CRS. This panel will address some of the practical experiences with dupilumab along with other biologics used for asthma and CRS.

At the upcoming virtual Summer Sinus Symposium, AIR is excited to sponsor 2 live panels. The first on November 14th builds on the biologic panel from the Fall meeting entitled “Biologics for nasal polyposis – what have we learned after one year on the market?” The second panel scheduled for November 15th “Unified airway and cough in the rhinology practice” will highlight the shared immunologic changes that can link CRS and asthma. As additional biologics become available for CRS management specifically, it becomes critical that we as rhinologists are at the forefront of both the surgical and medical management of CRS. These educational opportunities are efforts to keep us all there.

The mission of AIR is to support rhinologists in advancing the care and science of allergy and immunology as it pertains to the care of patients with rhinologic diseases, with a focus on providing educational support. All ARS members in good standing are eligible to participate in AIR leadership and activities. Please reach out to Amber Luong if you are interested in being more active in the AIR section.

Back to the top


Research and Grants Committee Update

Benjamin S. Bleier, MD, FARS

As I write this update from the American Rhinologic Society (ARS) Research and Grants Committee, the world continues to struggle with the COVID-19 pandemic. Among the surgical subspecialties, Otolaryngology has been one of the most impacted in light of the high viral titers found within the nose/nasopharynx and recognition of smell loss as an early symptom of the disease. With an array of novel pathophysiologic effects, the gauntlet has been thrown to the research community to understand the SARS-CoV-2 virus in an effort to develop improved tests, prevention strategies, treatments, and ultimately vaccines. Rhinologic researchers have answered this call and it is with pride that I can report that within the first 2 months of the pandemic the Rhinology community produced the largest number of COVID-19 related manuscripts (n = 41) among the Otolaryngology-Head and Neck Surgery sub-specialties (n = 235), which themselves produced the most scholarly work of any surgical field (n = 773).

This activity is emblematic of the broader commitment of the ARS to promote research and advance the science of Rhinology. The 2020-21 CORE grant cycle will represent a historic year for the ARS as we will be offering a record 6 grants for a total of $160,000 dollars. This year will feature a new grant mechanism, the “Women in Rhinology Grant” sponsored by Xoran Technologies, LLC which has been championed by Dr. Stephanie Shintani-Smith and others and is designed to fund projects which “may be related to any area of rhinology, with potential to clarify the role of artificial intelligence in sinonasal computed tomography”. Finally, 2020 represents the kick-off of the new mentoring program led by Dr. Corinna Levine which is designed to match unfunded ARS grant applicants with experienced mentors and provide seed funding to improve their chances of funding in subsequent cycles.

ARS remains deeply committed to its research mission of continuing to improve the quality of life of patients with rhinologic disease.

Back to the top


Friends in Research Campaign

From the strength of our recent Scientific Programs at both the Spring and Fall meetings, it is easy to see that research is at the heart of the future of our specialty. Each year, the ARS awards resident and new investigator grants in rhinology as a participating society of the AAO-HNSF CORE Grant program. New this year the ARS is also offering a three-year, multi-site Consortium Grant. Many of these small grants have served to support the early development of some of our brightest minds and future leaders of our specialty. Members and friends of the American Rhinologic Society have the opportunity to make a direct donation to the ARS in support of research.

With your support, we can continue to fund the studies that provide clinical insights valuable to the care of our patients. This work not only advances the care of our patients through scientific innovation, but also generates important data establishing the efficacy and cost effectiveness of our care. In the current financial landscape, this is equally important to ensure that our patients have access to the treatment necessary to address their complaints.

Past grants have been largely supported by donations from industry, but it is up to us to ensure the strength and vitality of our specialty. We encourage the members of the ARS to join us in investing in the future of rhinology by making a tax-deductible contribution.

Donate Now!

Titanium($3500+)

Melinda Thacker, MD

DIAMOND ($2500)

Lee Mandel, MD, FARS
Rodney Schlosser, MD, FARS
Michael Stewart, MD, FARS

PLATINUM ($1000)

Benjamin Bleier, MD, FARS
Roy Casiano, MD, FARS
Rakesh Chandra, MD, FARS
Charles Ebert, Jr., MD, FARS
Joseph Han, MD, FARS
Peter Hwang, MD, FARS
Robert Kern, MD, FARS
Devyani Lal, MD, FARS
R. Peter Manes, MD, FARS
James Palmer, MD, FARS
Doug Reh, MD, FARS
Brent Senior, MD, FARS
Michael Sillers, MD, FARS
Jonathan Ting, MD, FARS
Marilene Wang, MD, FARS
Kevin Welch, MD, FARS
Sarah Wise, MD, FARS

GOLD ($500)

Nadeem Akbar, MD
Do-Yeon Cho, MD
Jeb Justice, MD, FARS
Ken Yanagisawa, MD

SILVER ($250)

J. Noble Anderson, Jr., MD
Michael Cruz, MD, FARS
John Houck, MD
Francisco Krause Porter, MD

BRONZE ($100)

Anonymous
Sanford Archer, MD, FARS
Nick Debnath, MD
Rohit Garg, MD, FARS
Corinna Levine, MD, FARS
Fernanda Philippi, MD
Austin Rose, MD, FARS

FRIEND ($50)

Philip Harris, MD, FARS
Thomas Higgins, MD, FARS
Suzette Mikula, MD, FARS

*as of September 8, 2020 

Back to the top


International Forum of Allergy & Rhinology Highlights

The American Rhinologic Society (ARS), along with the American Academy of Otolaryngic Allergy (AAOA) and Wiley, are pleased to announce that the Impact Factor for our journal, International Forum of Allergy & Rhinology, has increased to 2.611, giving us a 7/42 ranking among all Otorhinolaryngology journals.

In the midst of a pandemic, our journal has received, and published, key research and commentary related to COVID-19. Please find the COVID-19 IFAR Virtual Issue here, making it freely accessible to everyone. IFAR publications related to COVID are among the highest cited articles in the medical literature.  In addition, IFAR downloads of all articles have doubled in the past 4 months alone.

COVID Collection Highlights:

OPTIONS FOR AUTHORS:
New Research Note manuscript option:
Research Notes (formerly Letters to the Editor) are peer-reviewed publications of clinical or laboratory observations, in abbreviated form. Research Notes are limited in scope relative to full length Research Manuscripts. Citation research shows that Research Notes are indexed in Medline, accessible to literature searches, and cited. A Research Notes must be limited to 900 words and 2 tables or figures.

See the complete IFAR ARTICLE PORTFOLIO options here

Back to the top


CRSwNP - Shared Decision Making Tool

Shared decision making (SDM) is a model based on patient oriented care in which patients are encouraged to play an active role in the medical decision that affect their treatment with physician’s input and guidance. In other words, physicians are taking into consideration the patient’s goal, cost, and preference to guide recommendation and treatments for their patient. While some patients may not want to have an active role in the management decision, recently patients are becoming more educated and interested in their treatment options. With that in mind, the American Rhinologic Society and the American College of Allergy Asthma and Immunology have partnered together to create a chronic sinusitis with nasal polyp (CRSwNP) SDM paper tool for otolaryngologists and allergist to use with their patients until the online SDM tool making is available. As FDA approved treatments for CRSwNP increase, this SDM tool will be modified to include the new treatment options.

Download the CRSwNP SDM Paper Tool

Back to the top